Thermo Fisher Scientific Inc.
TMO
$590.83
-$2.42-0.41%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.12B | 10.85B | 10.36B | 11.40B | 10.60B |
| Total Other Revenue | -- | 1.00M | -- | -- | -- |
| Total Revenue | 11.12B | 10.86B | 10.36B | 11.40B | 10.60B |
| Cost of Revenue | 6.53B | 6.44B | 6.12B | 6.55B | 6.26B |
| Gross Profit | 4.59B | 4.41B | 4.25B | 4.84B | 4.34B |
| SG&A Expenses | 2.10B | 2.13B | 2.06B | 2.18B | 2.08B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -44.00M | -- |
| Total Operating Expenses | 8.98B | 8.92B | 8.52B | 9.06B | 8.69B |
| Operating Income | 2.14B | 1.94B | 1.84B | 2.34B | 1.91B |
| Income Before Tax | 1.83B | 1.71B | 1.61B | 1.97B | 1.73B |
| Income Tax Expenses | 207.00M | 92.00M | 95.00M | 150.00M | 99.00M |
| Earnings from Continuing Operations | 1.62B | 1.62B | 1.51B | 1.82B | 1.63B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5.00M | -2.00M | -4.00M | 6.00M | -- |
| Net Income | 1.62B | 1.62B | 1.51B | 1.83B | 1.63B |
| EBIT | 2.14B | 1.94B | 1.84B | 2.34B | 1.91B |
| EBITDA | 2.82B | 2.61B | 2.55B | 3.08B | 2.66B |
| EPS Basic | 4.28 | 4.28 | 3.99 | 4.79 | 4.27 |
| Normalized Basic EPS | 3.34 | 3.01 | 2.85 | 3.74 | 2.96 |
| EPS Diluted | 4.27 | 4.28 | 3.98 | 4.78 | 4.25 |
| Normalized Diluted EPS | 3.34 | 3.01 | 2.84 | 3.73 | 2.94 |
| Average Basic Shares Outstanding | 378.00M | 378.00M | 378.00M | 382.00M | 382.00M |
| Average Diluted Shares Outstanding | 378.00M | 378.00M | 379.00M | 383.00M | 384.00M |
| Dividend Per Share | 0.43 | 0.43 | 0.43 | 0.39 | 0.39 |
| Payout Ratio | 10.09% | 10.02% | 9.89% | 8.14% | 9.20% |